How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Add Yahoo as a preferred source to see more of our stories on Google. logos of OpenAI Anadolu via Getty Images There’s interesting news coming from Sam Altman’s empire, a firm known for innovating as ...

When the World Wide Web surged into existence during the 1990s, we were introduced to the problem of how to actually find ...

Leslie Kramer is a writer for Institutional Investor, correspondent for CNBC, journalist for Investopedia, and managing editor for Markets Group. Robert Kelly is managing director of XTS Energy LLC, ...